Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $27.3 Million - $53.6 Million
428,400 Added 387.34%
539,000 $36 Million
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $13.5 Million - $22.3 Million
-133,600 Reduced 54.71%
110,600 $13.1 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $14 Million - $18.9 Million
-164,000 Reduced 40.18%
244,200 $26 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $23.4 Million - $35.2 Million
337,000 Added 473.31%
408,200 $40.6 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $6.86 Million - $9.01 Million
71,200 New
71,200 $7.35 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.